With the increasing prevalence of bacterial resistance, multidrug-resistant (MDR) infections have become a significant challenge. Consequently, the treatment of bacterial infections has become increasingly important. In response, targeted therapeutic strategies to combat pathogenic bacteria have emerged. Metal nanoparticles, particularly copper nanoparticles, offer a promising alternative to antibiotics due to their antimicrobial properties and are being explored as a potential solution
